Fresenius Kabi
Fresenius Kabi is a pharmaceutical manufacturing company headquartered in Bad Homburg, Hessen, Germany, specializing in I.V. generic drugs, infusion therapies, clinical nutrition, medical devices, transfusion technology products, biosimilars, and biopharmaceuticals.
Company Overview
Fresenius Kabi operates in the Pharmaceutical Manufacturing industry with a team size of 21,031 employees. The company is headquartered in Bad Homburg, Hessen, Germany. It is classified as a very large enterprise and has a significant global presence, impacting healthcare in regions including Africa, Asia Pacific, Europe, Latin America, and North America. Fresenius Kabi focuses on providing lifesaving medicines and technologies for critically and chronically ill patients.
Specialties
Fresenius Kabi specializes in several key areas including I.V. generic drugs, infusion therapies, clinical nutrition (both enteral and parenteral), medical devices, transfusion technology products, biosimilars, and biopharmaceuticals. The company is particularly focused on developing biosimilar drugs for autoimmune diseases and oncology, as well as offering apheresis machines and cell therapy devices within its medical technologies segment.
Products and Services
Fresenius Kabi develops, produces, and markets a comprehensive range of products including I.V. drugs, infusion therapy solutions, medical devices, and clinical nutrition options. The company provides parenteral and enteral nutrition solutions and is recognized for its innovative healthcare solutions aimed at improving patient outcomes. Its product portfolio includes biosimilars such as Idacio® (adalimumab) and Tyenne® (tocilizumab).
Corporate Strategy
Fresenius Kabi is committed to enhancing efficiencies in patient therapy and care through its Vision 2026 strategy, which is part of the #FutureFresenius program. The company emphasizes sustainability and corporate social responsibility, aiming to make a positive impact on healthcare systems worldwide. It has also been recognized for its supply chain innovation, receiving the 2024 Trailblazer Award from Premier Inc.
Global Impact
Fresenius Kabi touches the lives of approximately 450 million people every year through its products and services. The company plays a significant role in blood donation and saving lives, particularly through its engagement in transfusion technology and cell therapy solutions. Additionally, it supports initiatives such as PACIFHAN's annual World Home Artificial Nutrition Day to raise awareness about artificial nutrition treatments.